SEC Contract Filing

Filing Date: 2021-12-10

Document Content:
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>3
<FILENAME>lvac-20211231xex10d15.htm
<DESCRIPTION>EXHIBIT 10.15
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge 9.11.0.85--><!--Created on: 12/10/2021 09:29:09 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Exhibit 10.15</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">LAVA MEDTECH ACQUISITION CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">303 Wyman Street, Suite 300</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Waltham, Massachusetts 02451</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:11pt;">March 31, 2021</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">LAVA Medtech Sponsor LP</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">303 Wyman Street, Suite 300</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">Waltham, Massachusetts 02451</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;">RE: </font><u style="font-size:11pt;text-decoration:underline;text-decoration-color:#000000;">Securities Subscription Agreement</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:11pt;">&#160;Ladies and Gentlemen:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><font style="font-size:11pt;">This agreement (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Agreement</b><font style="font-size:11pt;">&#8221;) is entered into on March 31, 2021 by and between LAVA Medtech Sponsor LP, a Delaware limited partnership (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Subscriber</b><font style="font-size:11pt;">&#8221; or &#8220;</font><b style="font-size:11pt;font-weight:bold;">you</b><font style="font-size:11pt;">&#8221;), and LAVA Medtech Acquisition Corp., a Delaware corporation (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Company</b><font style="font-size:11pt;">&#8221;, &#8220;</font><b style="font-size:11pt;font-weight:bold;">we</b><font style="font-size:11pt;">&#8221; or &#8220;</font><b style="font-size:11pt;font-weight:bold;">us</b><font style="font-size:11pt;">&#8221;). Pursuant to the terms hereof, the Company hereby accepts the offer the Subscriber has made to purchase 2,875,000 &#160;shares (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Shares</b><font style="font-size:11pt;">&#8221;) of Class B common stock, $0.0001 par value per share (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Class B Common Stock</b><font style="font-size:11pt;">&#8221;) up to 375,000 of which are subject to forfeiture by you if the underwriters of the initial public offering (&#8220;</font><b style="font-size:11pt;font-weight:bold;">IPO</b><font style="font-size:11pt;">&#8221;) of units of the Company (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Units</b><font style="font-size:11pt;">&#8221;), do not fully exercise their over-allotment option (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Over-allotment Option</b><font style="font-size:11pt;">&#8221;). The Company and the Subscriber&#8217;s agreements regarding such Shares are as follows:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 0pt 18pt;"><font style="font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:bold;text-align:justify;">1.</b></font><b style="font-size:11pt;font-weight:bold;">Purchase of Sha